Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Side-by-side look at the strengths and weaknesses of zero-based budgeting and envelope systems to help you decide which suits your goals.
28,655 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Liberty Formula One stock trades around $83 after a strong Q4. Jim Cramer flags the pullback as a terrific buying opp...
Billionaire investor Peter Thiel arrives in Rome for a private four-day series on the Antichrist, drawing sharp quest...
Three AI ETFS split starkly in early 2026: one climbs while another fades, illustrating how fund design shapes AI bet...
As AI momentum intensifies, investors re-evaluate three tech leaders. This report examines MSFT, DELL, and INTEL to a...
California’s CEQA exemption is speeding residential projects, yet fault lines surface as opponents deploy new delay t...
Tuesday’s session centers on a slate of fresh analyst calls that push CoreWeave, Danaher, HPE, Intuit, Knight-Swift, ...
SpaceX’s public debut reframes who wins in venture capital, with Founders Fund and Andreessen Horowitz among the marq...
Saia stock swooned this week after a high-profile downgrade rattled traders, even as some metrics showed resilience. ...
The Dow Jones Industrial Average surged to a new record as investors rotated into value stocks while technology wobbl...
SK hynix kicked off trading at $170 on the Nasdaq, a 14% jump from the offering price of $149. The $26.5 billion deal...
A quiet ETF move by Urban Financial Advisory Corp shows a significant stake in AKRE Focus ETF. This article breaks do...